ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells

Marek Kubin(Amgen (United States)), Richard Armitage(Amgen (United States)), William C. Fanslow(Laboratoire d'Innovation Thérapeutique), Wilson Chin(IDEX Corporation (United States)), Anne-Marie Rousseau, Jürgen Müllberg(IDEX Corporation (United States)), David Cosman(IDEX Corporation (United States)), Jan Chalupny(Emory University), Linda Cassiano(Metis Design Corporation (United States)), D Ulrich
European Journal of Immunology
May 1, 2001
Cited by 155


Related Papers